The recall affects 15mg/ml (75 mg/5ml) nizatidine oral solutions packaged in 480 ml bottles the ndc number for the recalled medication is 60846-301-15 with lot numbers that include 06598004a. Acid reflux recall medication. (rxwiki news) the us food and drug administration (fda) has released an update about the recall of a common heartburn medication the fda has discovered that some medications used for acid reflux contain low levels of a possible cancer-causing impurity these medications are found under the names ranitidine (active ingredient) and zantac (brand) these drugs are available over the counter and.
acid reflux recall medication
En español | three drug companies are recalling popular heartburn medications that may contain “unacceptable levels” of a possible cancer-causing substance, federal officials say the recalls, posted by the food and drug administration (fda) this week, are the latest in a series that began in september 2019, when the fda alerted the public to the presence of a probable human carcinogen. The heartburn medications in the recall all contain the ingredient ranitidine. it's an acid reducer to lessen the frequency and severity of heartburn. it's also used to treat stomach ulcers.. A probable carcinogen that prompted the recall of several versions of blood pressure-lowering pills has been detected in the heartburn drug zantac and its generic versions, the food and drug.
